We are live on
!
Find out more
GCM
Gambit Capital Management Portfolio holdings
AUM
$172M
This Fund
S&P 500
This Quarter
Est. Return
+15.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$172M
AUM Growth
+$26.6M
(+18%)
Cap. Flow
+$9.41M
Cap. Flow
% of AUM
5.48%
Top 10 Holdings %
Top 10 Hldgs %
59.35%
Holding
109
New
19
Increased
50
Reduced
28
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23M |
| 2 |
Simplify Health Care ETF
PINK
|
+$1.73M |
| 3 |
Inspire 500 ETF
PTL
|
+$1.14M |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$913K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$680K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.02M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
+$458K |
| 3 |
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
|
+$297K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$267K |
| 5 |
Cboe Global Markets
CBOE
|
+$221K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.87% |
| 2 | Technology | 5.3% |
| 3 | Financials | 2.74% |
| 4 | Communication Services | 1.91% |
| 5 | Industrials | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
101
Novo Nordisk
NVO
$215B
| $204K | 0.12% |
+4,260
| New | +$183K |
|
102
NeoGenomics
NEO
$2.16B
| $161K | 0.09% |
+11,039
| New | +$107K |
|
103
PureCycle Technologies
PCT
$1.34B
| $156K | 0.09% |
19,200
| – | – |
|
|
104
Cboe Global Markets
CBOE
$32.3B
| – | – |
-785
| Closed | -$221K |
|
105
Ferguson
FERG
$45B
| – | – |
-921
| Closed | -$215K |
|
|
106
Janus Henderson AAA CLO ETF
JAAA
$30B
| – | – |
-9,094
| Closed | -$458K |
|
|
107
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| – | – |
0
| – | -$845K |
|
|
108
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| – | – |
0
| – | -$2.15M |
|
109
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| – | – |
-1,376
| Closed | -$202K |
|
Similar funds
SI
GIS
CFA
STA
NS
PW
WFP
CCG
Gambit Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Gambit Capital Management held 109 positions worth $172M, up 18% from $145M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Gambit Capital Management deployed $9.41M of net new capital in Q2 2026, opening 19 new positions and adding to 50 existing holdings. Its largest new stake was Inspire 500 ETF: 4,112 shares worth $1.18M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $1.02M trimmed.
- Gambit Capital Management's largest Q2 2026 buy was Inspire 500 ETF: 4,112 shares worth $1.18M.
- Gambit Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.23M increase.
- Gambit Capital Management's biggest Q2 2026 reduction was Eli Lilly, cutting an estimated $1.02M.
- Gambit Capital Management fully exited Janus Henderson AAA CLO ETF in Q2 2026, selling an estimated $458K.
- Gambit Capital Management's ten largest holdings make up 59% of its $172M portfolio in Q2 2026.
- Gambit Capital Management opened 19 new positions and closed 4 in Q2 2026.
- Gambit Capital Management's portfolio value rose 18% quarter-over-quarter to $172M.
Based on Gambit Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.